LH vs RVTY — Key Metrics

Metric LH (LABCORP HOLDINGS INC) RVTY (REVVITY INC)
Price370.78152.43
Market Cap30.11 Billion17.02 Billion
P/E (TTM)30.2267.75
P/B (Quarterly)3.3172.443
P/S (TTM)2.065.78
Net Profit Margin (TTM)6.98.6
Gross Margin (TTM)29.055.9
ROE (TTM)11.53.5
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

LABCORP HOLDINGS INC
vs
 
REVVITY INC
 
LABCORP HOLDINGS INC
vs
 
REVVITY INC
Performance Comparison
AI Model Recommendation
LH · LABCORP HOLDINGS INC

Underperform

-32
UnderperformOutperform
RVTY · REVVITY INC

Underperform

-46
UnderperformOutperform
Recommendation Summary

Both stocks are projected to underperform the market over the next year. If you have to make a choice, Upfront Recommendation: LH.

Financial Metrics
Prices delayed ~15 min
LH Metrics RVTY
$370.78 Price $152.43
— Market Capitalization —
30.22 Price to Earnings Ratio 67.75
2.06 Price to Sales 5.78
23.4 Price to FCF Ratio 28.24
7.12 Price to Gross Profit 10.35
7.59 Price to Current Assets 9.14

LH vs RVTY at a glance

Labcorp Holdings INC (LH) and Revvity INC (RVTY) are both Diagnostics & Research companies in the Healthcare sector. LH is the larger, at $30.1 billion in market value against $17.0 billion for RVTY, about 1.8 times the size.

On trailing-twelve-month figures, LH trades at 30.2 times trailing earnings and RVTY at 67.8; net profit margins are 6.9% and 8.6%.

The Upfront Investment model currently rates both Underperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.